Ember Therapeutics (CE) (USOTC:EMBT)
Historical Stock Chart
From Feb 2020 to Feb 2025
![Click Here for more Ember Therapeutics (CE) Charts. Click Here for more Ember Therapeutics (CE) Charts.](/p.php?pid=staticchart&s=NO%5EEMBT&p=8&t=15)
Embarcadero Technologies, Inc. (NASDAQ:EMBT), a leading provider of
strategic data management solutions, and Thoma Cressey Bravo, Inc., a
leading private equity investment firm, today announced the closing of
the previously announced merger between Embarcadero and EMBT Merger
Corp., an affiliate of Thoma Cressey Bravo. In the merger, each
outstanding share of Embarcadero common stock has been converted into
the right to receive $7.20 in cash, without interest. The transaction is
valued at approximately $200 million. As a result of the merger,
Embarcadero will no longer file periodic reports with the Securities and
Exchange Commission and shares of Embarcadero’s
common stock will no longer trade on the NASDAQ Global Select Market.
Embarcadero also announced today that it has reached an agreement in
principle with certain stockholders of Embarcadero that provides for the
settlement of each of the three stockholder derivative lawsuits that
were filed against Embarcadero relating to Embarcadero’s
historical stock option grant practices and related accounting and which
also sought to bring direct putative class claims relating to the
merger. In connection with this settlement, Embarcadero agreed to make
available additional information to its stockholders relating to the
merger, which additional information was set forth in definitive
additional proxy materials filed by Embarcadero with the Securities and
Exchange Commission on June 11, 2007. In return, the plaintiffs agreed
to the dismissal of the actions and release of all of the claims
asserted in the actions. In addition, Embarcadero agreed to pay the
legal fees and expenses of plaintiffs’
counsel, subject to the approval by the respective courts. The details
of the settlement will be set forth in a notice following preliminary
approval by the respective courts. Defendants deny plaintiffs’
allegations in the actions and agreed to settle the purported derivative
claims in order to avoid costly litigation and eliminate the risk of
delay to the closing of the merger.
About Embarcadero Technologies
Embarcadero Technologies, Inc. (NASDAQ:EMBT) delivers professional grade
database tools that companies use to design, develop and manage
databases and the data they contain. More than 12,000 customers
worldwide and over 90 of the Fortune 100 rely on Embarcadero’s
cross-platform tools to reduce complexity, improve productivity and
strengthen security. The Company’s flagship
database tools include: ER/Studio, DBArtisan, Rapid SQL and Change
Manager. Founded in 1993, Embarcadero Technologies is headquartered in
San Francisco with offices in Melbourne, Australia, Munich, Germany and
Maidenhead, United Kingdom. For more information, visit www.embarcadero.com.
About Thoma Cressey Bravo
Thoma Cressey Bravo, Inc. is a leading private equity investment firm
with more than 25 years of experience in building successful companies.
The firm has invested in many industry sectors and currently specializes
in the software, healthcare, business and financial services and
consumer industries. In the software industry, Thoma Cressey Bravo’s
portfolio of companies represents total earnings in excess of $400
million. The firm currently manages approximately $2 billion of equity
capital. For more information on Thoma Cressey Bravo, visit http://www.tcb.com.
Embarcadero, the Embarcadero Technologies logos and all other
Embarcadero Technologies product or service names are trademarks of
Embarcadero Technologies, Inc. All other trademarks are property of
their respective owners.